China Aoxing Pharmaceutical Company Receives Government Approval for Increased Ownership of its Main Operating Subsidiary, Hebei Aoxing; Amends Terms of the Acquisition Agreement

China Aoxing Pharmaceutical Company, Inc., a China-based pharmaceutical company specializing in analgesics and pain management products, including Oxycodone, Pholcodine, Naloxone and Tilidine, announced that the Chinese government has approved the Company’s acquisition of an additional 35 percent interest in Hebei Aoxing Pharmaceutical Group Co. Ltd. from its Chairman and Chief Executive Officer, Mr. Zhenjiang Yue.
Yahoo Finance